Tag: artificial intelligence in life sciences market size

  • Artificial Intelligence In Life Sciences Market Outlook 2025 – Insights for Executive and Strategic Planning

    Artificial Intelligence In Life Sciences Market Outlook 2025 – Insights for Executive and Strategic Planning

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the Artificial Intelligence In Life Sciences Market Grown from 2024 to 2025?

    The market size of artificial intelligence in life sciences has witnessed massive growth recently. It is predicted to increase from $2.92 billion in 2024 to $3.61 billion in 2025, with a compound annual growth rate (CAGR) of 23.7%. This growth trend during the historical period can be credited to factors such as increase in clinical trials, escalated use of AI in research and development sector, and a strong focus on developing precision medicine and personalized drugs.

    What Growth Rate Is Anticipated for the Artificial Intelligence In Life Sciences Market in the Coming Years?

    The market size for artificial intelligence in life sciences is predicted to witness significant growth in the coming years. It’s projected to escalate to $8.45 billion by 2029, with a compound annual growth rate (CAGR) of 23.7%. The anticipated growth during the forecast period can be ascribed to the rising interest in real-time, remote patient monitoring (rpm) systems, mounting demand for AI applications in drug discovery, and an increased propensity toward using AI in medical imagery analysis. Key trends expected to be observed over the forecast period comprise strategic alliances, novel product innovations, progress in technology, increased investments, and advanced research and development.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp

    Who Are the Leading Companies in the Artificial Intelligence In Life Sciences Market?

    Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Agueda, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Inserto, Sense.ly Inc., Subtle Medical Inc., Med sense Biometrics Limited, Immune, Atomwise Inc., Freenome Holdings Inc., Clouded Inc.

    What Are the Key Drivers of the Artificial Intelligence In Life Sciences Market?

    The escalating fascination towards real-time remote patient monitoring (RPM) systems is anticipated to boost the development of artificial intelligence in the life sciences sector. The RPM system is a technologically advanced healthcare solution tailored to track the health of patients outside conventional health grounds. The influence of AI in life sciences is substantial in remote patient monitoring as it offers constant, custom-made, and insights based on data that empower active healthcare management. For example, as per a poll by Livelink, a digital health company based in the US, in August 2023, the employment of remote patient monitoring (RPM) by medical practitioners rose by 20% in 2021 and hiked to 81% in 2022, showing a 305% hike. Hence, the growing fascination with real-time remote patient monitoring (RPM) systems is fueling the progression of artificial intelligence in the life sciences marketplace.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=13587&type=smp

    What Are the Key Market Segments in the Artificial Intelligence In Life Sciences Industry?

    The artificial intelligence in life sciences market covered in this report is segmented –

    1) By Offering: Software, Hardware, Services

    2) By Deployment: On-Premises, Cloud-Based

    3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trails, Precision And Personalized Medicine, Patient Monitoring

    Subsegments:

    1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)

    2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies

    3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services

    What Are the Latest Trends in the Artificial Intelligence In Life Sciences Market?

    Key players in the life sciences sector’s artificial intelligence market are concentrating on the creation of innovative products boosted by technological advancements, such as drug discovery software, to secure their market standing. Drug discovery software is a variety of software programs and apps developed to support researchers in the pharmaceutical and biotech industries in uncovering new drugs. For example, in December 2023, a groundbreaking drug discovery software, AIDDISON, was introduced by Merck, a Germany-based science and technology firm. This is the first software of its kind to integrate virtual molecule design with the practicality of manufacture, utilizing technologies such as generative AI, machine learning, and computer-aided drug design. AIDDISON has the ability to identify suitable drug candidates from an extensive range of possibilities, taking into account important characteristics like non-toxicity and solubility. Its capacity to act as a link between virtual molecule design and actual manufacture constitutes a significant usage of artificial intelligence in the life sciences industry.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

    What Are the Key Regional Markets in the Artificial Intelligence In Life Sciences Industry?

    North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13587

    This Report Delivers Insight On:

    1. How big is the artificial intelligence in life sciences market, and how is it changing globally?

    2. Who are the major companies in the artificial intelligence in life sciences market, and how are they performing?

    3. What are the key opportunities and risks in the artificial intelligence in life sciences market right now?

    4. Which products or customer segments are growing the most in the artificial intelligence in life sciences market?

    5. What factors are helping or slowing down the growth of the artificial intelligence in life sciences market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 2071930708

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • From Insight to Impact: Strategic Growth Mapping in the Artificial Intelligence In Life Sciences Market

    From Insight to Impact: Strategic Growth Mapping in the Artificial Intelligence In Life Sciences Market

    Discover trends, market shifts, and competitive outlooks for the artificial intelligence in life sciences industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    How Has the Artificial Intelligence In Life Sciences Market Growth Performance Trended Historically, And What Lies Ahead?

    Over the past few years, the market size of artificial intelligence within the life sciences sector has seen substantial expansion. Projections suggest an increase from $2.92 billion in 2024 to $3.61 billion in 2025, marking a compound annual growth rate (CAGR) of 23.7%. Factors such as a rise in clinical trials, enhanced adoption of AI in research and development, along with growing focus on precision medicine and personalized drug development have contributed to this historic growth.

    In the upcoming years, the market size of artificial intelligence in life sciences is predicted to witness tremendous growth, escalating to $8.45 billion by 2029, with a CAGR of 23.7%. The surge in growth during the forecast period can be linked to a growing interest in real-time remote patient monitoring systems, a rising demand for AI in discovering new drugs, and the broadening acceptance of AI in medical imaging analysis. Foresight for this period suggests key trends to comprise strategic collaborations, innovation in products, advancement in technology, investments, and research and development projects.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp

    What are the Fundamental Drivers and Innovations Shaping the Artificial Intelligence In Life Sciences Market?

    The escalating curiosity in real-time remote patient monitoring (RPM) technologies is expected to fuel the advancement of artificial intelligence in the life sciences sector. Remote patient monitoring system is a technologically advanced healthcare solution planned to supervise patients’ health beyond conventional healthcare environments. AI plays a pivotal role in the life sciences by offering continuous, personalized, and data-driven findings that facilitate proactive health management. For instance, as per a survey in August 2023 by Livelink, an American digital healthcare firm, the application of remote patient monitoring (RPM) by clinicians surged by 20% in 2021 to 81% in 2022, an overall increase of 305%. Consequently, the rising curiosity in real-time remote patient monitoring (RPM) tools is contributing to the expansion of artificial intelligence in the life sciences sector.

    How Is the Artificial Intelligence In Life Sciences Market Segmented?

    The artificial intelligence in life sciences market covered in this report is segmented –

    1) By Offering: Software, Hardware, Services

    2) By Deployment: On-Premises, Cloud-Based

    3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trails, Precision And Personalized Medicine, Patient Monitoring

    Subsegments:

    1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)

    2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies

    3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=13587&type=smp

    Which Regions Are Driving the Next Phase of the Artificial Intelligence In Life Sciences Market Growth?

    North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Key Trends Are Shaping the Future of the Artificial Intelligence In Life Sciences Market?

    Prominent firms in the life sciences artificial intelligence market are striving to maintain their market position through the advancement of innovative technology products, such as drug discovery software. Drug discovery software is a type of computer application aimed at aiding biotech and pharmaceutical researchers in the discovery of novel drugs. For example, in December 2023, Merck, a scientific and technology company based in Germany, introduced AIDDISON, a revolutionary drug discovery software. It is the first-ever software that links virtual molecule design to actual manufacturability utilizing generative AI, machine learning, and computer-supported drug design. AIDDISON can effectively pin down potential drug candidates from a plethora of possibilities while taking into account essential characteristics like non-toxicity and solubility. The software demonstrates a significant application of artificial intelligence in the sphere of life sciences by bridging the gap between virtual molecular design and actual manufacturability.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

    How Is the Artificial Intelligence In Life Sciences Market Defined and What Are Its Core Parameters?

    Artificial intelligence (AI) in life sciences refers to the application of AI technologies and techniques in various domains within the life sciences industry. The integration of AI in life sciences aims to enhance and expedite processes, improve decision-making, and generate valuable insights from complex data sets.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13587

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Key Insights into the Artificial Intelligence In Life Sciences Market: Trends, Growth Rate, and Opportunities Through 2034

    Key Insights into the Artificial Intelligence In Life Sciences Market: Trends, Growth Rate, and Opportunities Through 2034

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    How Are Key Drivers Contributing to the Growth and Expansion of the Artificial Intelligence In Life Sciences Market?

    Rising interest in real-time remote patient monitoring (RPM) systems is predicted to boost the expansion of artificial intelligence in the life sciences market. RPM system is a technological medical solution that tracks patient health outside standard healthcare environments. AI plays a crucial role in life sciences, particularly in RPM systems, by offering continuous, personalized, and data-driven insights for proactive health management. This was evidenced in Livelink’s survey in August 2023, a digital healthcare firm from the US, where clinical usage of RPM systems saw a 20% growth from 2021 to 2022, showing an overall increase of 305%. Hence, rising enthusiasm for real-time RPM systems fuels artificial intelligence’s growth in the life sciences market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp

    #How Does the ProjectedArtificial Intelligence In Life Sciences Market Growth Compare Over the Forecast Period?

    There has been tremendous growth in the market size of artificial intelligence within the life sciences sector in the past few years. The market, which is set to increase from $2.92 billion in 2024 to $3.61 billion in 2025, will do so at a compound annual growth rate (CAGR) of 23.7%. This substantial progress during the historic period is largely due to the rise in clinical trials, greater implementation of AI in research and development, as well as a strong focus on development of precision medicine and personalized drugs.

    Within the next few years, it’s projected that the market size for artificial intelligence in life sciences will witness exponential growth. The market is expected to elevate to $8.45 billion by 2029, with a compound annual growth rate (CAGR) of 23.7%. Factors contributing to this projected growth include heightened interest in real-time remote patient monitoring systems, a rising demand for AI in drug discovery, and an increased use of AI in medical imaging analysis. Key trends anticipated throughout this forecast period encompass strategic alliances, product innovation, technological progress, investments, and research and development initiatives.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13587

    What New Market Trends Are Reshaping theArtificial Intelligence In Life Sciences Market and Its Opportunities?

    Major corporations in the life sciences artificial intelligence market are concentrating their efforts on the launch of innovative products featuring technological advancements, such as software for drug discovery, to maintain their market standing. This software category is engineered to help researchers in pharmaceutical and biotechnology to facilitate the discovery of novel drugs. For instance, in December 2023, Merck, a scientific and technological company based in Germany, revealed AIDDISON – a revolutionary software program for drug discovery. This innovative tool, the first of its kind, merges virtual molecule design with the feasibility of real-world production, employing technologies such as generative AI, machine learning, and computer-aided drug design. AIDDISON is capable of effectively pinpointing potential drug candidates from a vast pool of options, evaluating key properties such as non-toxicity and solubility. Notably, its proficiency in bridging the gap between the virtual design of molecules and their real-world producibility marks a significant application of artificial intelligence within the life sciences sphere.

    Who Are the Leading Market Players Fueling Growth in the Artificial Intelligence In Life Sciences Market Trend?

    Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Agueda, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Inserto, Sense.ly Inc., Subtle Medical Inc., Med sense Biometrics Limited, Immune, Atomwise Inc., Freenome Holdings Inc., Clouded Inc.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

    How is the Global Artificial Intelligence In Life Sciences Market Segemented?

    The artificial intelligence in life sciences market covered in this report is segmented –

    1) By Offering: Software, Hardware, Services

    2) By Deployment: On-Premises, Cloud-Based

    3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trails, Precision And Personalized Medicine, Patient Monitoring

    Subsegments:

    1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)

    2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies

    3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=13587&type=smp

    Which Geographics are Influencing the Growth of the Artificial Intelligence In Life Sciences Market?

    North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Artificial Intelligence In Life Sciences Market 2025, By The Business Research Company:

    Artificial Intelligence Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-global-market-report

    Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-global-market-report

    Industrial Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/industrial-artificial-intelligence-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Artificial Intelligence In Life Sciences Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

    Artificial Intelligence In Life Sciences Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the artificial intelligence in life sciences market grown in recent years?

    The market size of artificial intelligence in the life sciences sector has seen substantial expansion recently. Market growth is anticipated to rise from $2.92 billion in 2024 to $3.61 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 23.7%. The growth observed during the historic term can be traced back to rising clinical trials numbers, increased integration of AI within research and development areas, and a significant focus on precision medicine and personalized drugs development.

    How is the artificial intelligence in life sciences market size expected to evolve during the forecast period?

    The market size for artificial intelligence in life sciences is projected to witness substantial growth in the coming years, expanding to $8.45 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 23.7%. The predicted growth for this period is largely due to the surge in interest in real-time remote patient monitoring systems, increased requirement for AI in drug discovery, and the growing acceptance of AI in medical imaging analysis. Key trends in the forecast period include strategic alliances, product breakthroughs, technological progress, financial investments, and research and development efforts.

    Get your artificial intelligence in life sciences market report here!

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

    Which key drivers are propelling the artificial intelligence in life sciences market’s growth?

    The burgeoning attraction towards real-time remote patient monitoring (RPM) systems is predicted to stimulate the expansion of the artificial intelligence in the life sciences market in the future. A remote patient monitoring system is an innovative healthcare solution, powered by technology, to observe patients’ health beyond conventional healthcare environments. The role of AI in life sciences is crucial to remote patient monitoring, offering ongoing, individualized, and data-oriented insights that facilitate proactive health management. For example, a survey held by Livelink, a digital healthcare firm based in the US, in August 2023 discovered that clinicians’ utilization of remote patient monitoring (RPM) escalated by 20% in 2021 to 81% in 2022, marking a 305% increase. Thus, the growing interest in real-time RPM systems is fuelling the advancement of artificial intelligence in the life sciences market.

    What are the market segments in the artificial intelligence in life sciences industry?

    The artificial intelligence in life sciences market covered in this report is segmented –

    1) By Offering: Software, Hardware, Services

    2) By Deployment: On-Premises, Cloud-Based

    3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trails, Precision And Personalized Medicine, Patient Monitoring

    Subsegments:

    1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)

    2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies

    3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp

    Which leading companies are shaping the growth of the artificial intelligence in life sciences market?

    Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Agueda, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Inserto, Sense.ly Inc., Subtle Medical Inc., Med sense Biometrics Limited, Immune, Atomwise Inc., Freenome Holdings Inc., Clouded Inc.

    What key trends are currently impacting the artificial intelligence in life sciences market’s development?

    Leading firms in the life sciences sector utilizing artificial intelligence are zeroing in on breakthrough products featuring advanced technology, such as software for drug discovery, in order to maintain their market standing. Drug discovery software is defined as a range of computer software and tools that aid researchers in the biotech and pharmaceutical sectors in the pursuit of novel drug discoveries. Taking this into account, in December 2023, Merck, a Germany-based company specializing in science and technology, launched AIDDISON, a revolutionary drug discovery software. This unprecedented software merges the design of virtual molecules with the practicality of real-world manufacturing, leveraging generative AI, machine learning, and computer-aided drug design. AIDDISON is adept at recognizing potential drug candidates from a myriad of possibilities, taking into account key factors such as the absence of toxicity and solubility. The software’s capability to link the design of virtual molecules with real-world manufacturability signifies a remarkable usage of artificial intelligence in the life sciences domain.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13587

    Which geographic areas are influencing the growth of the artificial intelligence in life sciences market?

    North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Artificial Intelligence Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-global-market-report

    Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-global-market-report

    Industrial Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/industrial-artificial-intelligence-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Artificial Intelligence In Life Sciences Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

    Artificial Intelligence In Life Sciences Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the artificial intelligence in life sciences market grown in recent years?

    The market size of artificial intelligence in the life sciences sector has seen substantial expansion recently. Market growth is anticipated to rise from $2.92 billion in 2024 to $3.61 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 23.7%. The growth observed during the historic term can be traced back to rising clinical trials numbers, increased integration of AI within research and development areas, and a significant focus on precision medicine and personalized drugs development.

    How is the artificial intelligence in life sciences market size expected to evolve during the forecast period?

    The market size for artificial intelligence in life sciences is projected to witness substantial growth in the coming years, expanding to $8.45 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 23.7%. The predicted growth for this period is largely due to the surge in interest in real-time remote patient monitoring systems, increased requirement for AI in drug discovery, and the growing acceptance of AI in medical imaging analysis. Key trends in the forecast period include strategic alliances, product breakthroughs, technological progress, financial investments, and research and development efforts.

    Get your artificial intelligence in life sciences market report here!

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

    Which key drivers are propelling the artificial intelligence in life sciences market’s growth?

    The burgeoning attraction towards real-time remote patient monitoring (RPM) systems is predicted to stimulate the expansion of the artificial intelligence in the life sciences market in the future. A remote patient monitoring system is an innovative healthcare solution, powered by technology, to observe patients’ health beyond conventional healthcare environments. The role of AI in life sciences is crucial to remote patient monitoring, offering ongoing, individualized, and data-oriented insights that facilitate proactive health management. For example, a survey held by Livelink, a digital healthcare firm based in the US, in August 2023 discovered that clinicians’ utilization of remote patient monitoring (RPM) escalated by 20% in 2021 to 81% in 2022, marking a 305% increase. Thus, the growing interest in real-time RPM systems is fuelling the advancement of artificial intelligence in the life sciences market.

    What are the market segments in the artificial intelligence in life sciences industry?

    The artificial intelligence in life sciences market covered in this report is segmented –

    1) By Offering: Software, Hardware, Services

    2) By Deployment: On-Premises, Cloud-Based

    3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trails, Precision And Personalized Medicine, Patient Monitoring

    Subsegments:

    1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)

    2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies

    3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp

    Which leading companies are shaping the growth of the artificial intelligence in life sciences market?

    Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Agueda, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Inserto, Sense.ly Inc., Subtle Medical Inc., Med sense Biometrics Limited, Immune, Atomwise Inc., Freenome Holdings Inc., Clouded Inc.

    What key trends are currently impacting the artificial intelligence in life sciences market’s development?

    Leading firms in the life sciences sector utilizing artificial intelligence are zeroing in on breakthrough products featuring advanced technology, such as software for drug discovery, in order to maintain their market standing. Drug discovery software is defined as a range of computer software and tools that aid researchers in the biotech and pharmaceutical sectors in the pursuit of novel drug discoveries. Taking this into account, in December 2023, Merck, a Germany-based company specializing in science and technology, launched AIDDISON, a revolutionary drug discovery software. This unprecedented software merges the design of virtual molecules with the practicality of real-world manufacturing, leveraging generative AI, machine learning, and computer-aided drug design. AIDDISON is adept at recognizing potential drug candidates from a myriad of possibilities, taking into account key factors such as the absence of toxicity and solubility. The software’s capability to link the design of virtual molecules with real-world manufacturability signifies a remarkable usage of artificial intelligence in the life sciences domain.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13587

    Which geographic areas are influencing the growth of the artificial intelligence in life sciences market?

    North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Artificial Intelligence Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-global-market-report

    Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-global-market-report

    Industrial Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/industrial-artificial-intelligence-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Artificial Intelligence In Life Sciences Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

    Artificial Intelligence In Life Sciences Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How Will the Artificial Intelligence In Life Sciences Market’s Growth Rate Evolve Over the Forecast Period to 2034?

    The market size for artificial intelligence in the life sciences sector has witnessed a significant surge in recent times. Expectations indicate a rise from $2.92 billion in 2024 to $3.61 billion in 2025, showing a compound annual growth rate (CAGR) of 23.7%. The historic progression in this market can be credited to the growing count of clinical trials, amplified adoption of AI in research and development, and a substantial focus on the advancement of precision medicine and bespoke drugs.

    The market size of artificial intelligence in life sciences is projected to experience skyrocketing growth in the coming years, reaching $8.45 billion by 2029, with a compound annual growth rate (CAGR) of 23.7%. The reasons for the anticipated surge during the forecast period include the growing interest in real-time remote patient monitoring (RPM) systems, an increasing need for AI in the domain of drug discovery, and higher adoption rates of AI in the field of medical imaging analysis. Significant trends expected to be seen during the forecast period are strategic alliances, innovative solutions, progress in technology, investments, and research and development.

    Which Drivers Are Expected to Have the Greatest Impact on the artificial intelligence in life sciences Market’s Growth?

    The growth of artificial intelligence in the life sciences market is expected to be propelled by the escalating interest in real-time remote patient monitoring (RPM) systems. These technology-led healthcare solutions are designed to supervise patients’ health beyond traditional healthcare environments. AI plays a crucial role in the life sciences when it comes to remote patient monitoring, offering continuous, personalized, and data-focused perspectives that facilitate proactive healthcare management. For example, a study carried out by Livelink, a digital healthcare company based in the US, revealed in August 2023 that the utilization of RPM by clinicians increased by 20% from 2021 till 2022, resulting in a total growth of 305%. Therefore, the rising interest in real-time remote patient monitoring (RPM) systems is fuelling the expansion of artificial intelligence in the life sciences market.

    Get Your Free Sample of the Global Artificial Intelligence In Life Sciences Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp

    Who Are the Influential Players Reshaping the Artificial Intelligence In Life Sciences Market Landscape?

    Major companies operating in the artificial intelligence in life sciences market report are:

    • Google LLC_x000D_

    • Microsoft Corporation_x000D_

    • Intel Corporation_x000D_

    • IBM Corporation_x000D_

    • Medtronic PLC_x000D_

    What New and Evolving Trends Are Having a Lasting Impact on the Artificial Intelligence In Life Sciences Market?

    Key players in the artificial intelligence for life sciences market are concentrating on developing ingenious products with technological advancements, such as software for drug discovery, to maintain their presence significantly. Drug discovery software is a collective term for computer programs and applications created to help researchers in pharmaceutical and biotech fields in the pursuit of novel drugs. To illustrate, in December 2023, Merck, a science and technology firm based in Germany, introduced AIDDISON, a revolutionary drug discovery software. As the first of its kind, AIDDISON merges virtual molecule design with real-world manufacturability, integrating generative AI, machine learning, and computer-aided drug design. It effectively identifies viable drug candidates from a multitude of options, taking into account key properties like non-toxicity and solubility. Its unique capacity to bridge the divide between virtual molecule design and real-life manufacturability marks a significant application of artificial intelligence in the life sciences domain.

    Get Instant Access to the Global Artificial Intelligence In Life Sciences Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

    Which Key Segments Define the Structure of the Artificial Intelligence In Life Sciences Market and Their Growth Potential?

    The artificial intelligence in life sciences market covered in this report is segmented –

    1) By Offering: Software, Hardware, Services

    2) By Deployment: On-Premises, Cloud-Based

    3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trails, Precision And Personalized Medicine, Patient Monitoring

    Subsegments:

    1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)

    2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies

    3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services

    Which Geographic Locations Are Critical to the Growth of the Artificial Intelligence In Life Sciences Market?

    North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Key Characteristics That Define the Artificial Intelligence In Life Sciences Market?

    Artificial intelligence (AI) in life sciences refers to the application of AI technologies and techniques in various domains within the life sciences industry. The integration of AI in life sciences aims to enhance and expedite processes, improve decision-making, and generate valuable insights from complex data sets.

    Browse Through More Similar Reports By The Business Research Company:

    Artificial Intelligence Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-global-market-report

    Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-global-market-report

    Industrial Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/industrial-artificial-intelligence-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Artificial Intelligence In Life Sciences Market Growth Analysis Till 2033 By The Business Research Company

    Artificial Intelligence In Life Sciences Market Growth Analysis Till 2033 By The Business Research Company

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Artificial intelligence (AI) has emerged as a transformative force in the life sciences sector, driving significant advancements in research, patient care, and drug development. This blog explores the remarkable growth of AI in life sciences, highlighting key trends, future projections, and major factors contributing to this expansion.

    Current Market Size and Growth

    Exponential Growth in Recent Years

    • Market Size in 2023: $2.35 billion
    • Market Size in 2024: $2.92 billion
    • Compound Annual Growth Rate (CAGR): 24.2%

    The recent surge in market size can be attributed to:

    • Clinical Trials: Increasing number of trials leveraging AI for efficiency and accuracy.
    • Research and Development: Widespread adoption of AI in R&D activities.
    • Precision Medicine: High emphasis on developing personalized drugs and treatments.

    Future Market Projections

    Sustained Exponential Growth

    • Market Size in 2028: $6.82 billion
    • CAGR: 23.6%

    Key drivers for future growth include:

    • Remote Patient Monitoring (RPM): Growing interest in real-time RPM systems.
    • Drug Discovery: Increasing demand for AI-driven drug discovery processes.
    • Medical Imaging Analysis: Rising adoption of AI in analyzing medical images.

    Read More On The Artificial Intelligence In Life Sciences Market Report 2024 – https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

    Trends and Innovations

    Strategic Partnerships and Product Innovations

    • Collaborations: Increasing number of strategic partnerships in AI and life sciences.
    • Technological Advancements: Continuous innovation in AI technologies and applications.
    • Investments: Significant investments in AI research and development.

    Surge in Remote Patient Monitoring

    The rising interest in RPM systems is significantly boosting AI adoption in life sciences:

    • RPM Systems: Technology-driven solutions for monitoring patients outside traditional settings.
    • AI Integration: Providing continuous, personalized, and data-driven healthcare insights.
    • Survey Insights: According to Livelink, clinicians’ use of RPM grew by 305% from 2021 to 2022.

    Technological Advancements

    Major companies are focusing on innovative AI products to maintain market leadership:

    • Drug Discovery Software: Advanced AI tools assisting in drug discovery.
    • Example: Merck’s AIDDISON software, launched in December 2023, integrates generative AI, machine learning, and computer-aided drug design to identify non-toxic and soluble drug candidates.

    Strategic Acquisitions

    Varix Acquires Start-Up.ai

    • Acquisition Date: June 2023
    • Objective: Strengthening AI and machine learning capabilities for pharma commercial operations.
    • Impact: Enhancing Varix’s AI-driven commercial optimization platform.

    Major Players in the Market

    Leading companies driving innovation in AI for life sciences include:

    • Google LLC
    • Microsoft Corporation
    • Intel Corporation
    • IBM Corporation
    • Medtronic PLC
    • Nvidia Corporation
    • Novo Nordisk A/S
    • Siemens Healthineers AG
    • Philips Healthcare

    Market Segmentation

    By Offering

    • Software
    • Hardware
    • Services

    By Deployment

    • On-Premises
    • Cloud-Based

    By Application

    • Drug Discovery
    • Medical Diagnosis
    • Biotechnology
    • Clinical Trials
    • Precision and Personalized Medicine
    • Patient Monitoring

    Regional Insights

    • North America: Largest market in 2023.
    • Asia-Pacific: Expected to be the fastest-growing region in the forecast period.

    Conclusion

    The artificial intelligence in life sciences market is poised for continued exponential growth, driven by advancements in technology, increasing demand for AI applications in healthcare, and strategic industry partnerships. As AI continues to revolutionize the life sciences sector, it will play a crucial role in enhancing patient care, accelerating drug discovery, and advancing personalized medicine.

    Request for A Sample Of The Global Artificial Intelligence In Life Sciences Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=13587&type=smp